What type of study is this?

This is a Experimental Study study.

September 20, 2025Cancer Research

Abstract A056: Patient avatar models for ovarian cancer: Predicting patient response to treatment

View Full Paper

Ask AI

Bookmark

Patient-derived microtumors accurately predict responses to standard-of-care therapy, improving personalized treatment strategies.
The new platform enables therapeutic screening and retains the tumor's native microenvironment for meaningful assessment.
Surgically collected tumors were cultured for weeks using a microgel-based scaffold, assessed for viability and drug response.
This innovative approach addresses limitations of existing ovarian cancer models and could accelerate patient-specific treatment predictions.

No takes yet. Share an insight, caveat, or question.

A novel 3D ex vivo platform predicts drug response in high-grade serous ovarian cancer microtumors, highlighting advances in personalized treatment.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

A novel 3D ex vivo platform predicts drug response in high-grade serous ovarian cancer microtumors, highlighting advances in personalized treatment.